Goldman Sachs Group »

Novabay Pharmaceuticals shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Novabay Pharmaceuticals (NBY) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Novabay Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Novabay Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novabay Pharmaceuticals by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $589k 104k 5.64

More positions owned by Goldman Sachs Group

Nvidia Corporation CMN (NVDA)
Apple CMN (AAPL)
Microsoft Corp CMN (MSFT)
Spdr S&p 500 Etf Tr CMN (SPY)
Tesla CMN (TSLA)
Alphabet CMN (GOOGL)
Amazon CMN (AMZN)
Broadcom CMN (AVGO)
Meta Platforms CMN (META)
Invesco Qqq Tr CMN (QQQ)
Vanguard Index Fds CMN (VOO)
Alphabet CMN (GOOG)
Ishares Tr CMN (IVV)
Eli Lilly & Co CMN (LLY)
Jpmorgan Chase & Co. CMN (JPM)

View all positions for Goldman Sachs Group

Top funds holding Novabay Pharmaceuticals

BlackRock
Vanguard Group
Geode Capital Management
State Street Corporation
Northern Trust
Goldman Sachs Group
Charles Schwab Investment Management
Jane Street
Susquehanna International
C2C Wealth Management
Qube Research & Technologies
UBS Group
Apollon Wealth Management
Bank of New York Mellon
OMERS Administration Corporation

View all funds holding Novabay Pharmaceuticals